Q1 2025 |
99 |
$229M |
+$10.5M |
-$11.4M |
-$859K |
BRKB, ABBV, CSCO, PAYX, ABT
|
13F-HR |
4/23/2025, 11:04 AM |
Q4 2024 |
96 |
$225M |
+$2.1M |
-$17.5M |
-$15.4M |
BRKB, ABBV, CSCO, PAYX, ABT
|
13F-HR |
1/21/2025, 08:26 AM |
Q3 2024 |
99 |
$242M |
+$8.04M |
-$4.37M |
+$3.67M |
ABBV, BRKB, DLR, PID, PAYX
|
13F-HR |
11/8/2024, 08:12 PM |
Q2 2024 |
94 |
$220M |
+$7.13M |
-$5.16M |
+$1.97M |
ABBV, BRKB, DLR, QCOM, PID
|
Restatement |
8/15/2024, 02:50 PM |
Q1 2024 |
94 |
$216M |
+$38.2M |
-$5.77M |
+$32.5M |
ABBV, BRKB, DLR, PAYX, CSCO
|
13F-HR |
4/23/2024, 03:37 PM |
Q4 2023 |
54 |
$178M |
+$7.15M |
-$1.31M |
+$5.85M |
ABBV, DLR, BRKB, PID, PAYX
|
13F-HR |
2/6/2024, 09:27 AM |
Q3 2023 |
53 |
$162M |
+$8.21M |
-$298K |
+$7.91M |
ABBV, BRKB, CSCO, DLR, PID
|
13F-HR |
10/25/2023, 10:34 AM |
Q2 2023 |
93 |
$187M |
+$8.99M |
-$1.43M |
+$7.56M |
ABBV, BRKB, PID, CSCO, DLR
|
13F-HR |
7/24/2023, 01:55 PM |
Q1 2023 |
90 |
$180M |
+$27M |
-$2.2M |
+$24.8M |
ABBV, PID, BRKB, CSCO, FSLR
|
13F-HR |
4/25/2023, 09:16 AM |
Q4 2022 |
57 |
$164M |
+$2.87M |
-$3.73M |
-$865K |
ABBV, CSCO, BRKB, JNJ, PID
|
13F-HR |
1/30/2023, 09:09 AM |
Q3 2022 |
94 |
$171M |
+$1.46M |
-$3.17M |
-$1.71M |
ABBV, CSCO, JNJ, BRKB, PAYX
|
13F-HR |
10/20/2022, 09:41 AM |
Q2 2022 |
97 |
$183M |
+$4.22M |
-$144K |
+$4.07M |
ABBV, JNJ, CSCO, PID, BRKB
|
Restatement |
7/28/2022, 09:08 AM |
Q1 2022 |
104 |
$211M |
+$5.01M |
-$4.94M |
+$71.9K |
ABBV, CSCO, BRKB, PAYX, PID
|
13F-HR |
5/2/2022, 12:14 PM |
Q4 2021 |
108 |
$216M |
+$10.8M |
-$6.67M |
+$4.09M |
ABBV, CSCO, PAYX, ABT, BRKB
|
13F-HR |
1/13/2022, 12:17 PM |
Q3 2021 |
106 |
$203M |
+$11M |
-$9.22M |
+$1.82M |
ABBV, CSCO, PID, BRKB, JNJ
|
13F-HR |
10/28/2021, 10:13 AM |
Q2 2021 |
103 |
$209M |
+$5.71M |
-$6.46M |
-$752K |
ABBV, CSCO, PAYX, JNJ, BRKB
|
13F-HR |
8/4/2021, 10:33 AM |
Q1 2021 |
99 |
$196M |
+$11.6M |
-$13.4M |
-$1.78M |
ABBV, CSCO, PAYX, JNJ, ABT
|
13F-HR |
4/27/2021, 09:42 AM |
Q4 2020 |
93 |
$183M |
+$9.06M |
-$6.12M |
+$2.94M |
ABBV, CSCO, ABT, PAYX, JNJ
|
Restatement |
2/4/2021, 08:23 AM |
Q3 2020 |
88 |
$162M |
+$9.04M |
-$3.11M |
+$5.93M |
ABBV, ABT, CSCO, INTC, JNJ
|
13F-HR |
11/4/2020, 09:08 AM |
Q2 2020 |
82 |
$156M |
+$6.36M |
-$3.97M |
+$2.39M |
ABBV, CSCO, INTC, BDX, JNJ
|
13F-HR |
7/28/2020, 01:16 PM |
Q1 2020 |
81 |
$136M |
+$11.7M |
-$1.73M |
+$9.94M |
CSCO, INTC, ABT, BDX, ABBV
|
Restatement |
4/22/2020, 12:11 PM |
Q4 2019 |
80 |
$166M |
+$9.21M |
-$3.5M |
+$5.72M |
BDX, ABBV, INTC, CSCO, ABT
|
13F-HR |
2/14/2020, 07:59 AM |
Q3 2019 |
79 |
$155M |
+$6.77M |
-$1.85M |
+$4.91M |
CSCO, BDX, ABT, HAS, INTC
|
13F-HR |
10/21/2019, 09:40 AM |
Q2 2019 |
80 |
$151M |
+$4.65M |
-$828K |
+$3.83M |
CSCO, ABT, BDX, INTC, JNJ
|
13F-HR |
8/1/2019, 11:28 AM |
Q1 2019 |
82 |
$148M |
+$9.36M |
-$4.08M |
+$5.29M |
CSCO, ABT, BDX, INTC, JNJ
|
Restatement |
4/18/2019, 09:02 AM |
Q4 2018 |
81 |
$135M |
+$2.14M |
-$5.52M |
-$3.39M |
ABT, CSCO, BDX, INTC, JNJ
|
13F-HR |
2/5/2019, 08:09 AM |
Q3 2018 |
96 |
$164M |
+$44.7M |
-$5.57M |
+$39.1M |
BDX, CSCO, ABT, JNJ, INTC
|
Restatement |
10/16/2018, 10:19 AM |
Q2 2018 |
60 |
$77.6M |
+$10.3M |
-$6.16M |
+$4.14M |
JNJ, BDX, IP, EMR, OMC
|
13F-HR |
7/16/2018, 10:09 AM |
Q1 2018 |
84 |
$135M |
+$5.38M |
-$1.58M |
+$3.81M |
GWW, INTC, CSCO, BDX, ABT
|
13F-HR |
4/17/2018, 11:58 AM |
Q4 2017 |
86 |
$140M |
+$6.22M |
-$804K |
+$5.42M |
INTC, BDX, JNJ, GWW, ABT
|
13F-HR |
1/31/2018, 10:48 AM |
Q3 2017 |
83 |
$131M |
+$9.56M |
-$6.58M |
+$2.98M |
CVS, JNJ, BDX, ABT, IP
|
13F-HR |
10/17/2017, 10:44 AM |
Q2 2017 |
84 |
$135M |
+$2.68M |
-$371K |
+$2.31M |
HAS, JNJ, CVS, BDX, IP
|
13F-HR |
7/17/2017, 10:08 AM |
Q1 2017 |
81 |
$133M |
+$3.8M |
-$5.3M |
-$1.5M |
CVS, GEXXXX, JNJ, BDX, HAS
|
13F-HR |
5/16/2017, 02:42 PM |
Q4 2016 |
80 |
$129M |
+$2.77M |
-$6.74M |
-$3.98M |
GEXXXX, CVS, JNJ, IP, BDX
|
13F-HR |
1/30/2017, 11:08 AM |
Q3 2016 |
79 |
$134M |
+$2.6M |
-$1.8M |
+$799K |
T, BDX, CVS, GEXXXX, JNJ
|
13F-HR |
10/11/2016, 09:49 AM |
Q2 2016 |
78 |
$134M |
+$14.4M |
-$704K |
+$13.7M |
T, CVS, GEXXXX, BDX, JNJ
|
13F-HR |
7/13/2016, 12:04 PM |
Q1 2016 |
64 |
$117M |
+$7.41M |
-$4.79M |
+$2.62M |
T, CVS, GEXXXX, BDX, JNJ
|
13F-HR |
4/20/2016, 12:10 PM |
Q4 2015 |
68 |
$112M |
+$3.76M |
-$3.13M |
+$632K |
CVS, BMY, T, GEXXXX, BDX
|
13F-HR |
1/19/2016, 01:49 PM |
Q3 2015 |
70 |
$111M |
+$7.73M |
-$472K |
+$7.26M |
CVS, T, BMY, GEXXXX, BDX
|
13F-HR |
10/13/2015, 11:29 AM |
Q2 2015 |
77 |
$123M |
+$8.42M |
-$4.35M |
+$4.06M |
CVS, BMY, T, IP, BDX
|
13F-HR |
7/15/2015, 10:43 AM |
Q1 2015 |
73 |
$124M |
+$7.98M |
-$1.63M |
+$6.35M |
CVS, BMY, IP, T, BDX
|
13F-HR |
4/15/2015, 11:56 AM |
Q4 2014 |
76 |
$123M |
+$6.08M |
-$1.09M |
+$5M |
CVS, ABBV, BMY, T, IP
|
13F-HR |
1/20/2015, 01:47 PM |
Q3 2014 |
77 |
$122M |
+$6.9M |
-$1.1M |
+$5.8M |
T, ABBV, CVS, BMY, IP
|
13F-HR |
10/21/2014, 11:29 AM |
Q2 2014 |
76 |
$121M |
+$7.93M |
-$3.43M |
+$4.5M |
T, CVS, ABBV, PBA, BMY
|
13F-HR |
7/24/2014, 09:17 AM |
Q1 2014 |
68 |
$112M |
+$2.33M |
-$2.59M |
-$264K |
T, CVS, ABBV, BMY, PBA
|
13F-HR |
4/24/2014, 12:13 PM |
Q4 2013 |
73 |
$118M |
|
|
|
T, BMY, CVS, ABBV, PBA
|
13F-HR |
1/16/2014, 02:14 PM |